Maxine B. Cooper v. Laboratory Corporation of America Holdings, Incorporated, and Esab Group, Incorporated Roche Biomedical Laboratories, Incorporated

150 F.3d 376, 14 I.E.R. Cas. (BNA) 207, 1998 U.S. App. LEXIS 16345, 1998 WL 400019
CourtCourt of Appeals for the Fourth Circuit
DecidedJuly 17, 1998
Docket97-1428
StatusPublished
Cited by27 cases

This text of 150 F.3d 376 (Maxine B. Cooper v. Laboratory Corporation of America Holdings, Incorporated, and Esab Group, Incorporated Roche Biomedical Laboratories, Incorporated) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Maxine B. Cooper v. Laboratory Corporation of America Holdings, Incorporated, and Esab Group, Incorporated Roche Biomedical Laboratories, Incorporated, 150 F.3d 376, 14 I.E.R. Cas. (BNA) 207, 1998 U.S. App. LEXIS 16345, 1998 WL 400019 (4th Cir. 1998).

Opinion

Affirmed by published opinion. Judge ERVIN wrote the opinion, in which Judge HAMILTON and Chief Judge WILSON joined.

OPINION

ERVIN, Circuit Judge:

Maxine Cooper, the appellant in this diversity case, brought suit against her employer, Esab Corporation, after she was fired because her urine tested positive for alcohol in violation of company policy. Cooper also sued the laboratory that did the urine test, Laboratory Corporation of America Holdings (“LCAH”), alleging negligence, defamation, and intentional interference with contractual relations. Cooper settled her claims against Esab, but continued to prosecute her claims against LCAH, the appellee in this case. She now appeals the district court’s grant of summary judgment in favor of LCAH on all her claims. We affirm the judgment of the district court.

I.

On March 21, 1994, Cooper submitted a urine sample to her employer, Esab, for drug and alcohol testing. Cooper had agreed to undergo random testing for drug and alcohol use when she resumed her employment after participating in the Employee Assistance Program for gambling addiction. It is unclear why Cooper’s gambling addiction should have led to random alcohol and drug testing, but such was the agreement between her and her employer on her return to work.

Cooper is a diabetic, and she does not consume alcohol. She controls her diabetes through diet and occasionally through use of a medication called Glynase 6, which is used almost exclusively for the treatment of diabetes. Generally, when submitting a urine sample for testing, an employee is required to list the medications she is currently taking. When Cooper submitted her urine sample for testing, she informed Esab that she took Glynase 6, which Esab duly noted on the form that accompanied Cooper’s urine sample when it was transmitted to the laboratory.

LCAH did an immunoassay test on Cooper’s urine, which tested positive for alcohol at a level of .134%. LCAH then performed a gas chromatograph test on Cooper’s urine, which indicated a blood alcohol level of .258%. Normally, the disparity between the immunoassay test and the gas chromato-graph test should be no more than 10 — 15%, much less than the discrepancy in this case. The disparity is consistent with Cooper’s theory that her urine tested positive for alcohol due to her diabetes; the urine of a diabetic may contain glucose, which will ferment into alcohol when mixed with yeast or bacteria. Continuing fermentation would explain the disparity between the initial test results and the results of the gas chromatograph test. Fermentation can be prevented by adding a preservative, sodium fluoride, to the urine sample, or by refrigerating the urine sample. LCAH followed neither of those procedures.

After LCAH reported the test results to Greg Cain, Esab’s designated representative, Cain informed Cooper that her urine tested positive for alcohol. Cooper informed him that she was a diabetic and did not consume alcohol, and that the test must be mistaken. She provided another urine sample on April 4, which Cain submitted to LCAH for test *379 ing. That sample again tested positive for alcohol. Cooper had also gone to her family doctor to have her blood and urine tested for alcohol on April 5. The results of that test, which she gave to Cain, were negative. Cain and Esab, however, chose to rely exclusively on LCAH’s results, and on April 7, Cain terminated Cooper for having violated Esab’s policy concerning alcohol consumption on the job.

Cooper initially filed an action against both Esab and LCAH. Her claims against Esab included breach of employment contract, retaliatory discharge, violations of the South Carolina Disabilities Act, and defamation. Cooper settled all claims against Esab, leaving only this action against LCAH.

II.

We review de novo grants of summary judgment. Kimsey v. City of Myrtle Beach, 109 F.3d 194, 195 (4th Cir.1997). In order to prevail on a motion for summary judgment, the moving party must “show that there is no genuine issue as to any material fact and that the moving party is entitled to a judgment as a matter of law.” Fed.R.Civ.P. 56(c). The evidence of the nonmoving party is to be believed, and all inferences drawn in her favor. Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 255, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986).

III.

Cooper claims negligence, defamation; and intentional interference with contractual relations against LCAH.

A.

Cooper suggests LCAH was negligent in two ways: first, she contends that the lab should have changed its testing procedures to counteract the likely effect of Cooper’s diabetes on the results of the urine test; and second, that the lab should have informed Esab that her urine likely tested positive for alcohol because of her diabetes and not because of the ingestion of alcohol. She does not allege that LCAH reported inaccurate results.

Cooper can recover in negligence only by showing that (1) LCAH owed her a duty of care; (2) LCAH breached that duty by negligent act or omission; and (3) her damage proxmiately resulted from that injury. Snow v. City of Columbia, 305 S.C. 544, 409 S.E.2d 797, 803 (1991). In a professional negligence cause of action, a plaintiff must establish that “the professional failed to conform to the generally recognized and accepted practices in his profession.” Doe v. American Red Cross Blood Servs., 297 S.C. 430, 377 S.E.2d 323, 326 (1989). Professional negligence is usually proved through the use of expert testimony. Hoeffner v. Citadel, 311 S.C. 361, 429 S.E.2d 190, 192 (1993).

In order to prevail on her negligence claim, Cooper first has to establish that LCAH owed her a duty. LCAH does not have a statutorily established duty to Cooper. Neither South Carolina nor the federal government has issued guidelines on workplace testing for private employers. LCAH is certified to provide testing services for federal government agencies under the Mandatory Guidelines for Federal Workplace Drug Testing Programs (“Guidelines”), 59 F.R. 29908 (June 9, 1994). The Guidelines do not, however, govern a laboratory’s duties to private employers, though private employers must be notified if a laboratory loses its certification. 59 F.R. at 29914-15. The Guidelines also do not apply to alcohol testing.

Surprisingly, given the increased frequency of workplace testing for drug and alcohol use, the case law on the issue is rather sparse. Neither South Carolina, whose law applies in this diversity action, nor the Fourth Circuit has expressed an opinion on the issue. Those courts that have are somewhat divided. The overall trend is for courts to recognize the existence of a limited duty on the part of the laboratory to employees who are the subject of the tests. See, e.g., Stinson v. Physicians Immediate Care, Ltd.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Maxwell Kadel v. Dale Folwell
100 F.4th 122 (Fourth Circuit, 2024)
WALLS v. FORD MOTOR COMPANY
M.D. North Carolina, 2022
Blackjewel, L.L.C. v. United Bank
S.D. West Virginia, 2022
KADEL v. FOLWELL
M.D. North Carolina, 2022
Shaw v. Psychemedics Corporation
826 S.E.2d 281 (Supreme Court of South Carolina, 2019)
Rodriguez v. Laboratory Corp. of America Holdings
13 F. Supp. 3d 121 (D.C. Circuit, 2014)
AVX Corporation v. United States
518 F. App'x 130 (Fourth Circuit, 2013)
Pasternack v. Laboratory Corp. of America
892 F. Supp. 2d 540 (S.D. New York, 2012)
Mayfield v. National Ass'n for Stock Car Auto Racing, Inc.
713 F. Supp. 2d 527 (W.D. North Carolina, 2010)
Quisenberry v. Compass Vision, Inc.
618 F. Supp. 2d 1223 (S.D. California, 2007)
United States v. Rosen
487 F. Supp. 2d 721 (E.D. Virginia, 2007)
Greenlee v. Godlan Incorporated
78 F. App'x 299 (Fourth Circuit, 2003)
JEFFERSON CTY. COM. ATTY'S OFFICE v. Kaplan
65 S.W.3d 916 (Kentucky Supreme Court, 2002)
Jefferson County Commonwealth Attorney's Office v. Kaplan
65 S.W.3d 916 (Kentucky Supreme Court, 2001)
Andrews v. Commonwealth of VA
Fourth Circuit, 2000

Cite This Page — Counsel Stack

Bluebook (online)
150 F.3d 376, 14 I.E.R. Cas. (BNA) 207, 1998 U.S. App. LEXIS 16345, 1998 WL 400019, Counsel Stack Legal Research, https://law.counselstack.com/opinion/maxine-b-cooper-v-laboratory-corporation-of-america-holdings-ca4-1998.